WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
With Djokovic awaiting the winner, Murray trails Hanfmann at rain
Bill allowing parents to be fined for child's criminal offenses heads to Tennessee governor
Philippine troops kill 12 suspected Muslim rebels in clash that wounded seven soldiers
A new report says Mexico has abandoned protection of loggerhead sea turtles
Why US Catholics are planning pilgrimages in communities across the nation
California legislators prepare to vote on a crackdown on utility spending
California legislators prepare to vote on a crackdown on utility spending
Venezuela's president meets with accuser in ongoing criminal probe into human rights abuse
Everybody may love Raymond, but Ray Romano loves Peter Boyle
Jury deliberating in Iraq Abu Ghraib prison abuse civil case; contractor casts blame on Army
Britain's new bonkers EV: Callum Skye is an £80k electric buggy built in Warwickshire
Arizona judge declares mistrial in the case of a rancher accused of fatally shooting a migrant